Institute of Pharmacology and Toxicology, Technical University of Munich (TUM), Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Handb Exp Pharmacol. 2024;285:27-54. doi: 10.1007/164_2023_676.
Adrenoceptors are class A G-protein-coupled receptors grouped into three families (α-, α-, and β-adrenoceptors), each one including three members. All nine corresponding adrenoceptor genes display genetic variation in their coding and adjacent non-coding genomic region. Coding variants, i.e., nucleotide exchanges within the transcribed and translated receptor sequence, may result in a difference in amino acid sequence thus altering receptor function and signaling. Such variants have been intensely studied in vitro in overexpression systems and addressed in candidate-gene studies for distinct clinical parameters. In recent years, large cohorts were analyzed in genome-wide association studies (GWAS), where variants are detected as significant in context with specific traits. These studies identified two of the in-depth characterized 18 coding variants in adrenoceptors as repeatedly statistically significant genetic risk factors - p.Arg389Gly in the β- and p.Thr164Ile in the β-adrenoceptor, along with 56 variants in the non-coding regions adjacent to the adrenoceptor gene loci, the functional role of which is largely unknown at present. This chapter summarizes current knowledge on the two coding variants in adrenoceptors that have been consistently validated in GWAS and provides a prospective overview on the numerous non-coding variants more recently attributed to adrenoceptor gene loci.
肾上腺素受体是 A 类 G 蛋白偶联受体,分为三组(α-、α-和 β-肾上腺素受体),每组包括三个成员。所有九个相应的肾上腺素能受体基因在其编码和相邻的非编码基因组区域都显示出遗传变异。编码变异,即在转录和翻译的受体序列内的核苷酸交换,可能导致氨基酸序列的差异,从而改变受体功能和信号转导。这些变体在体外过表达系统中进行了深入研究,并在候选基因研究中针对不同的临床参数进行了研究。近年来,在全基因组关联研究 (GWAS) 中对大型队列进行了分析,其中变体在特定特征的背景下被检测为显著。这些研究确定了深入研究的两个肾上腺素能受体 18 个编码变体中的两个作为反复具有统计学意义的遗传风险因素 - β 肾上腺素受体中的 p.Arg389Gly 和 β 肾上腺素受体中的 p.Thr164Ile,以及与肾上腺素能受体基因座相邻的非编码区域中的 56 个变体,其功能作用目前尚不清楚。本章总结了在 GWAS 中一直得到验证的两个编码变体的最新知识,并对最近归因于肾上腺素能受体基因座的众多非编码变体进行了前瞻性概述。